| Literature DB >> 32215728 |
Markus Paschold1, Florentine Huettl1, Werner Kneist1, Christian Boedecker1, Alicia Poplawski2, Tobias Huber1, Hauke Lang3.
Abstract
PURPOSE: In hepatobiliary surgery, preoperative three-dimensional reconstruction based on CT or MRI can be provided externally or by local, semi-automatic software. We analyzed the time expense and quality of external versus local three-dimensional reconstructions.Entities:
Keywords: 3D segmentation; Liver surgery; Surgical education; Surgical planning; Virtual surgery
Mesh:
Year: 2020 PMID: 32215728 PMCID: PMC7239814 DOI: 10.1007/s00423-020-01862-7
Source DB: PubMed Journal: Langenbecks Arch Surg ISSN: 1435-2443 Impact factor: 3.445
Characteristics of selected patients (n = 20)
| Characteristics | Value |
|---|---|
| Age (years, mean (range)) | 62 (22–79) |
| Gender | |
| Male | 13 (65%) |
| Female | 7 (35%) |
| Underlying disease | |
| Colorectal liver metastases | 10 (50%) |
| Hepatocellular carcinoma | 7 (35%) |
| Focal nodular hyperplasia | 1 (5%) |
| Breast cancer metastases | 1 (5%) |
| Echinococcus multilocularis | 1 (5%) |
| Operation type | |
| Laparoscopic | 8 (40%) |
| Open | 12 (60%) |
| Type of resection | |
| Minor resection | |
| Non-anatomical resection | 4 (20%) |
| Segmentectomy | 10 (50%) |
| Bisegmentectomy | 2 (10%) |
| Major resection | |
| Left hemihepatectomy | 1 (5%) |
| Extended left hemihepatectomy | 3 (15%) |
Fig. 1Reconstruction time of the CT scans from all patients. Solid lines represent total reconstruction time. Dashed lines represent the time for reconstruction step 1
Reconstruction time
| Learning phase | Control phase | Difference | ||
|---|---|---|---|---|
| Time (min) | Time (min) | Time (min) | ||
| Median (IQR) | Median (IQR) | Median (%) | ||
| Resident 1 | ||||
| Reconstruction step 1 | 97 (93;163) | 54 (51;70) | 43 (44) | 0.019* |
| Reconstruction step 2 | 80 (46;91) | 27 (13;34) | 53 (66) | 0.001* |
| Total reconstruction time | 196 (157;227) | 88 (64;158) | 108 (55) | 0.002* |
| Resident 2 | ||||
| Reconstruction step 1 | 75 (62;77) | 62 (47;85) | 13 (17) | 0.407 |
| Reconstruction step 2 | 70 (41;100) | 13 (9;19) | 57 (81) | 0.001* |
| Total reconstruction time | 146 (108;171) | 76 (53;100) | 70 (48) | 0.003* |
| Resident 3 | ||||
| Reconstruction step 1 | 68 (58;123) | 61 (45;68) | 7 (10) | 0.182 |
| Reconstruction step 2 | 77 (68;181) | 50 (44;74) | 27 (35) | 0.035* |
| Total reconstruction time | 141 (132;299) | 119 (88;132) | 22 (15) | 0.023* |
| Total | ||||
| Reconstruction step 1 | 77 (64;97) | 57 (48;71) | 20 (26) | 0.002* |
| Reconstruction step 2 | 77 (48;102) | 29 (13;45) | 48 (62) | < 0.001* |
| Total reconstruction time | 152 (134;206) | 88 (68;120) | 64 (42) | < 0.001* |
Learning phase: external reconstruction available for comparison; control phase: external reconstruction not available for comparison. IQR, interquartile range
1Adjusted for multiple testing
*Significant
Quality assessment of the control phase (n = 15): comparison of liver volume results
| Correlation | One sample | ||||
|---|---|---|---|---|---|
| ICC | Resident 1 | Resident 2 | Resident 3 | ||
| 95% CI | 95% CI | 95% CI | |||
| Liver | 0.998 | < 0.01* | |||
| Tumor | 0.998 | < 0.01* | |||
| Left PV | 0.994 | < 0.01* | |||
| Right PV | 0.990 | < 0.01* | |||
| Lateral PV | 0.997 | < 0.01* | |||
| Medial PV | 0.992 | < 0.01* | |||
| Anterior PV | 0.972 | < 0.01* | [− 0.068;0.137] | ||
| Posterior PV | 0.981 | < 0.01* | [− 0.084;0.042] | [− 0.106; 0.053] | |
| Segment 1 | 0.976 | < 0.01* | [− 0.134;0.146] | [− 0.303; | [− 0.194;0.127] |
| Segment 2 | 0.997 | < 0.01* | [− 0.146; | [− 0.255; | |
| Segment 3 | 0.988 | < 0.01* | [− 0.143;0.097] | [− 0.040;0.141] | |
| Segment 4a | 0.933 | < 0.01* | [− 0.215;0.029] | [− 0.034;0.338] | [− 0.108;0.043] |
| Segment 4b | 0.922 | < 0.01* | [− 0.335;0.153] | [− 0.829;0.002] | [− 0.076;0.081] |
| Segment 5 | 0.937 | < 0.01* | [− 0.039;0.131] | [− 0.424;0.400] | [− 0.197;0.116] |
| Segment 6 | 0.958 | < 0.01* | [− 0.174;0.048] | [− 0.272;0.129] | |
| Segment 7 | 0.976 | < 0.01* | [− 0.100;0.049] | [− 0.411;0.169] | |
| Segment 8 | 0.976 | < 0.01* | [− 0.128;0.057] | [− 0.109;0.002] | |
| Left HV | 0.992 | < 0.01* | |||
| Middle HV | 0.976 | < 0.01* | |||
| Right HV | 0.995 | < 0.01* | |||
CI, confidence interval. Values in italics are proven equivalence
1Adjusted for multiple testing
*Significant
Fig. 2Liver reconstruction (Pat. ID 10). External reconstruction (a): Three-dimensional visualization of a patient’s liver with five breast cancer metastases and multiple intrahepatic cystic lesions (yellow). Portal vein (pink) and hepatic vein (color coded) are visualized. In this figure, hepatic vein territories including an inferior right hepatic vein are color coded.
Image courtesy of © 2019 MeVis Medical Solutions AG, Bremen, Germany.
Local reconstruction (b): Three-dimensional visualization of a patient’s liver with five breast cancer metastases (purple) and multiple intrahepatic cystic lesions (yellow). Portal vein (pink) and hepatic vein (blue) are visualized. In this figure, hepatic vein territories including an inferior right hepatic vein are color coded.